Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: For patients who have a ventricular tachyarrhythmic event, implantable cardioverter-defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy. METHODS: Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy. RESULTS: The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (+/-SD) follow-up period of 22.5+/-5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29). CONCLUSIONS: In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 [controlled-trials.com].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial, 30 which randomly assigned 128 ICD patients with a history of ventricular arrhythmia and myocardial infarction to ablation or usual care, arrhythmia recurrence was significantly decreased from 33% to 12% with ablation.”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [30]
Citations
Cites
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Marchlinski, F. E., Callans, D. J., Gottlieb, C. D., & Zado, E. (2000) · Circulation · doi:10.1161/01.cir.101.11.1288 · Cited by 1,220
Moss, A. J., Greenberg, H., Case, R. B., Zareba, W., Hall, W. J., Brown, M. W., Daubert, J. P., McNitt, S., Andrews, M. L., & Elkin, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000150390.04704.b7 · Cited by 597
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Guiraudon, G., Fontaine, G., Frank, R., Escande, G., Etievent, P., & Cabrol, C. (1978) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62923-2 · Cited by 404
Electrical storm in patients with transvenous implantable cardioverter-defibrillators
Credner, S. C., Klingenheben, T., Mauss, O., Sticherling, C., & Hohnloser, S. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00495-1 · Cited by 376
Arenal, A., Glez-Torrecilla, E., Ortiz, M., Villacastín, J., Fdez-Portales, J., Sousa, E., del Castillo, S., Perez de Isla, L., Jimenez, J., & Almendral, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02623-2 · Cited by 343
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Research works printed but not linked: 1
- Stevenson WG, 2005, Curr Opin Cardiol, 20, 42
Cited by
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., De Hert, S., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,141
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs
Sapp, J. L., Wells, G. A., Parkash, R., Stevenson, W. G., Blier, L., Sarrazin, J.-F., Thibault, B., Rivard, L., Gula, L., Leong-Sit, P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513614 · Cited by 863
Towbin, J. A., McKenna, W. J., Abrams, D. J., Ackerman, M. J., Calkins, H., Darrieux, F. C. C., Daubert, J. P., de Chillou, C., DePasquale, E. C., Desai, M. Y., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.05.007 · Cited by 846
Kuck, K.-H., Schaumann, A., Eckardt, L., Willems, S., Ventura, R., Delacrétaz, E., Pitschner, H.-F., Kautzner, J., Schumacher, B., & Hansen, P. S. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61755-4 · Cited by 799
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
Aliot, E. M., Stevenson, W. G., Almendral-Garrote, J. M., Bogun, F., Calkins, C. H., Delacretaz, E., Della Bella, P., Hindricks, G., Jaïs, P., Josephson, M. E., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.04.030 · Cited by 770
Self-citationTung, R., Vaseghi, M., Frankel, D. S., Vergara, P., Di Biase, L., Nagashima, K., Yu, R., Vangala, S., Tseng, C.-H., Choi, E.-K., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.05.036 · Cited by 499
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al-Khatib, S. M., Anter, E., et al. (2019) · EP Europace · doi:10.1093/europace/euz132 · Cited by 475
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al-Khatib, S. M., Anter, E., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2019.03.002 · Cited by 431
Di Biase, L., Santangeli, P., Burkhardt, D. J., Bai, R., Mohanty, P., Carbucicchio, C., Dello Russo, A., Casella, M., Mohanty, S., Pump, A., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.044 · Cited by 422
Aliot, E. M., Stevenson, W. G., Almendral-Garrote, J. M., Bogun, F., Calkins, C. H., Delacretaz, E., Bella, P. D., Hindricks, G., Jais, P., Josephson, M. E., et al. (2009) · Europace · doi:10.1093/europace/eup098 · Cited by 416
Self-citationDinov, B., Fiedler, L., Schönbauer, R., Bollmann, A., Rolf, S., Piorkowski, C., Hindricks, G., & Arya, A. (2014) · Circulation · doi:10.1161/circulationaha.113.003063 · Cited by 390
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., Dorian, P., Huikuri, H., Kim, Y.-H., Knight, B., et al. (2014) · Europace · doi:10.1093/europace/euu194 · Cited by 327
“Catheter ablation has been demonstrated to reduce appropriate ICD shocks for patients with ischaemic cardiomyopathy when utilized after a first presentation with VA [147].”
BackgroundLinde, C., Bongiorni, M. G., Birgersdotter-Green, U., Curtis, A. B., Deisenhofer, I., Furokawa, T., Gillis, A. M., Haugaa, K. H., Lip, G. Y. H., Van Gelder, I., et al. (2018) · EP Europace · doi:10.1093/europace/euy067 · Cited by 296
Catheter Ablation for Ventricular Tachycardia
Stevenson, W. G., & Soejima, K. (2007) · Circulation · doi:10.1161/circulationaha.106.655720 · Cited by 299
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., Dorian, P., Huikuri, H., Kim, Y.-H., Knight, B., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.07.024 · Cited by 288
Bohnen, M., Stevenson, W. G., Tedrow, U. B., Michaud, G. F., John, R. M., Epstein, L. M., Albert, C. M., & Koplan, B. A. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.017 · Cited by 274
TANNER, H., HINDRICKS, G., VOLKMER, M., FURNISS, S., KÜHLKAMP, V., LACROIX, D., DE CHILLOU, C., ALMENDRAL, J., CAPONI, D., KUCK, K., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01563.x · Cited by 265
Characterization of the Arrhythmogenic Substrate in Ischemic and Nonischemic Cardiomyopathy
Nakahara, S., Tung, R., Ramirez, R. J., Michowitz, Y., Vaseghi, M., Buch, E., Gima, J., Wiener, I., Mahajan, A., Boyle, N. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.041 · Cited by 237
Substrate Mapping for Ventricular Tachycardia
Josephson, M. E., & Anter, E. (2015) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2015.09.001 · Cited by 221
“The SMASH-VT (Substrate Mapping and Ablation in Sinus Rhythm to Halt VT) study, a prospective, randomized, and controlled trial in 127 patients with history of MI and VT who were randomized to implantable cardioverter-defibrillator (ICD) alone or ICD plus substrate ablation demonstrated a 70% reduction in arrhythmic e…”
MethodSelf-citationVentricular Tachycardia and Sudden Cardiac Death
Koplan, B. A., & Stevenson, W. G. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.3.289 · Cited by 206
Della Bella, P., Baratto, F., Vergara, P., Bertocchi, P., Santamaria, M., Notarstefano, P., Calò, L., Orsida, D., Tomasi, L., Piacenti, M., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.059598 · Cited by 204
Cardiac magnetic resonance–aided scar dechanneling: Influence on acute and long-term outcomes
Andreu, D., Penela, D., Acosta, J., Fernández-Armenta, J., Perea, R. J., Soto-Iglesias, D., de Caralt, T. M., Ortiz-Perez, J. T., Prat-González, S., Borràs, R., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.018 · Cited by 198
“Introduction Substrate-based catheter ablation is an effective therapeutic option in patients with recurrent episodes of scar-related ventricular tachycardia (VT).(1,2) However, data obtained from large series still show a high rate of recurrence after ablation, which highlights the need for further improvement of the…”
BackgroundJCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
Nogami, A., Kurita, T., Abe, H., Ando, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0637 · Cited by 200
Irie, T., Yu, R., Bradfield, J. S., Vaseghi, M., Buch, E. F., Ajijola, O., Macias, C., Fujimura, O., Mandapati, R., Boyle, N. G., et al. (2015) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002637 · Cited by 203
Perez-David, E., Arenal, Á., Rubio-Guivernau, J. L., del Castillo, R., Atea, L., Arbelo, E., Caballero, E., Celorrio, V., Datino, T., Gonzalez-Torrecilla, E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.043 · Cited by 198
SOEJIMA, K., & YADA, H. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01417.x · Cited by 202
Tzou, W. S., Frankel, D. S., Hegeman, T., Supple, G. E., Garcia, F. C., Santangeli, P., Katz, D. F., Sauer, W. H., & Marchlinski, F. E. (2015) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002310 · Cited by 190
“In the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial, a randomized controlled trial that investigated a strategy of early substrate-based VT ablation among patients with ischemic heart disease, freedom from treated ventricular arrhythmias was 88% at 2 years.(5) Using a similar st…”
BackgroundMethodBella, P. D., Baratto, F., Tsiachris, D., Trevisi, N., Vergara, P., Bisceglia, C., Petracca, F., Carbucicchio, C., Benussi, S., Maisano, F., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000872 · Cited by 189
“Early CA, before or after the first ICD shock, was performed in the SMASH trial and led to a 73% reduction of ICD shocks and a trend toward improved survival in ablated patients.(11) In the VTACH trial, CA was applied after the first tolerated VT episode, prolonging the time to VT recurrence and reducing its incidence…”
BackgroundMethodWang, Y., Cuculich, P. S., Zhang, J., Desouza, K. A., Vijayakumar, R., Chen, J., Faddis, M. N., Lindsay, B. D., Smith, T. W., & Rudy, Y. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002152 · Cited by 185
Anter, E., Tschabrunn, C. M., Buxton, A. E., & Josephson, M. E. (2016) · Circulation · doi:10.1161/circulationaha.116.021955 · Cited by 186
Self-citationWillems, S., Tilz, R. R., Steven, D., Kääb, S., Wegscheider, K., Gellér, L., Meyer, C., Heeger, C.-H., Metzner, A., Sinner, M. F., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043400 · Cited by 190
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia
Arenal, Á., Ávila, P., Jiménez-Candil, J., Tercedor, L., Calvo, D., Arribas, F., Fernández-Portales, J., Merino, J. L., Hernández-Madrid, A., Fernández-Avilés, F. J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.01.050 · Cited by 185
Santangeli, P., Muser, D., Maeda, S., Filtz, A., Zado, E. S., Frankel, D. S., Dixit, S., Epstein, A. E., Callans, D. J., & Marchlinski, F. E. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.03.004 · Cited by 185
“Quantitative data synthesis: CA trials Efficacy of CA to prevent recurrent VT Data on number of recurrent VT episodes were retrievable from all CA trials.(13-18) Over a mean of 14±8 months follow-up, VT recurred in 90/233 (39%) patients randomized to CA versus 105/194 (54%) patients who received control medical therap…”
InfluentialEzzat, V. A., Lee, V., Ahsan, S., Chow, A. W., Segal, O., Rowland, E., Lowe, M. D., & Lambiase, P. D. (2015) · Open Heart · doi:10.1136/openhrt-2014-000198 · Cited by 176
Kuck, K.-H., Tilz, R. R., Deneke, T., Hoffmann, B. A., Ventura, R., Hansen, P. S., Zarse, M., Hohnloser, S. H., Kautzner, J., & Willems, S. (2017) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004422 · Cited by 172
“In SMASH-VT, at least one VT zone was programmed, which was, however, not further specified.(9) Consequently, for future ICD trials, predefined ICD programming criteria would be important.”
BackgroundMethodTung, R., Xue, Y., Chen, M., Jiang, C., Shatz, D. Y., Besser, S. A., Hu, H., Chung, F.-P., Nakahara, S., Kim, Y.-H., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.060039 · Cited by 170
Cardiac Arrest and Sudden Cardiac Death
Myerburg, R. J., & Castellanos, A. (2012) · Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine · doi:10.1016/b978-1-4377-0398-6.00041-x · Cited by 163
Ventricular Tachycardia Ablation: Evolution of Patients and Procedures Over 8 Years
Sacher, F., Tedrow, U. B., Field, M. E., Raymond, J.-M., Koplan, B. A., Epstein, L. M., & Stevenson, W. G. (2008) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.108.769471 · Cited by 166
JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
Nogami, A., Kurita, T., Abe, H., Ando, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12491 · Cited by 164
Ventricular Tachycardia Ablation
Guandalini, G. S., Liang, J. J., & Marchlinski, F. E. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2019.09.015 · Cited by 178
Komatsu, Y., Cochet, H., Jadidi, A., Sacher, F., Shah, A. J., Derval, N., Scherr, D., Pascale, P., Roten, L., Denis, A., et al. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.000191 · Cited by 157
“342 Catheter ablation is an effective therapeutic option in the management of drug-resistant postinfarction ventricular tachycardia (VT).(1,2) The procedure often relies on substratebased approaches because of hemodynamic instability, multiple VT morphologies, and noninducibility rendering the VT unmappable.”
Backgroundy, L. N.-F., Mitroi, C. D., Lozano, I. F., García‐Touchard, A., Toquero, J., Castro‐Urda, V., Díaz, J. A. F., Pérez-Pereira, E., Beltrán-Correas, P., Segovia, J., et al. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.968008 · Cited by 155
“Diabetes mellitus 52 (32) 24 (26) 29 (41) 0.”
Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia
Marchlinski, F. E., Haffajee, C. I., Beshai, J. F., Dickfeld, T.-M. L., Gonzalez, M. D., Hsia, H. H., Schuger, C. D., Beckman, K. J., Bogun, F. M., Pollak, S. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.11.041 · Cited by 154
“This hypothesis is supported by results of the SMASH-VT (Substrate Mapping and Ablation in Sinus Rhythm to Halt VT) study, which showed significant improvement in ICD events and survival free from ICD shocks at 2 years with prophylactic RFCA for VT (14).”
BackgroundResultKumar, S., Romero, J. E., Mehta, N. K., Fujii, A., Kapur, S., Baldinger, S. H., Barbhaiya, C. R., Koplan, B. A., John, R. M., Epstein, L. M., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.07.001 · Cited by 154
Transcoronary Ethanol Ablation for Recurrent Ventricular Tachycardia After Failed Catheter Ablation
Tokuda, M., Sobieszczyk, P. S., Eisenhauer, A. C., Kojodjojo, P., Inada, K., Koplan, B. A., Michaud, G. F., John, R. M., Epstein, L. M., Sacher, F., et al. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966283 · Cited by 151
“[1,2] Although percutaneous and surgical approaches to the pericardial space now allow RFCA to target epicardial VTs, there are still a number of patients in whom VT cannot be eliminated with both endocardial and epicardial approach.”
BackgroundImplantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis
Schuller, J. L., Zipse, M. M., Crawford, T. C., Bogun, F. M., Beshai, J. F., Patel, A. R., Sweiss, N., Nguyen, D. T., Aleong, R. G., Varosy, P. D., et al. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02350.x · Cited by 151
Complications of Catheter Ablation of Ventricular Tachycardia
Peichl, P., Wichterle, D., Pavlů, L., Cihak, R. J., Aldhoon, B., & Kautzner, J. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001530 · Cited by 147
Palaniswamy, C., Kolte, D. S., Harikrishnan, P., Khera, S., Aronow, W. S., Mujib, M. U., Mellana, W. M., Eugenio, P. L., Lessner, S., Ferrick, A. M., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.07.012 · Cited by 144
Cluitmans, M. J. M., Brooks, D. H., MacLeod, R., Dössel, O., Guillem, M. S., van Dam, P. M., Švehlíková, J., He, B., Sapp, J. L., Wang, L., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01305 · Cited by 144
Cardiac Magnetic Resonance-Guided Ventricular Tachycardia Substrate Ablation
Soto‐Iglesias, D., Penela, D., Jáuregui, B., Acosta, J., Fernández‐Armenta, J., Linhart, M., Zucchelli, G., Syrovnev, V., Záraket, F., Teres, C. C., et al. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2019.11.004 · Cited by 144
Vaseghi, M., Hu, T. Y., Tung, R. H., Vergara, P., Frankel, D. S., Biase, L. D., Tedrow, U. B., GORNBEIN, J. A., Yu, R., Mathuria, N. S., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.05.007 · Cited by 140
“) 8/49 (16) 31/46 (67) 15/35 (43) 5/22 (23) <0.”
Vergara, P., Tung, R. H., Vaseghi, M., Brombin, C., Frankel, D., Biase, L. D., Nagashima, K., Tedrow, U. B., Tzou, W. S., Sauer, W. H., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.08.022 · Cited by 139
Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, A. J., Elliot, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.01.001 · Cited by 160
Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure
Santangeli, P., Rame, J. E., Birati, E. Y., & Marchlinski, F. E. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.047 · Cited by 145
“, 1999 (112) 46 47 59 18 64 17 31 (67) 28 (60) 35 8 38 19 15 (33)* 24 (51)* 4 (9) 3 (6)”
BackgroundSchmidt, B., Chun, K. R. J., Baensch, D., Antz, M., Koektuerk, B., Tilz, R. R., Metzner, A., Ouyang, F. O., & Kück, K. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.08.010 · Cited by 135
Noninducibility and Late Potential Abolition
Silberbauer, J., Olóriz, T., Maccabelli, G., Tsiachris, D., Baratto, F., Vergara, P., Mizuno, H., Bisceglia, C., Marzi, A., Sora, N., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001239 · Cited by 133
“Pre-emptive substrate-based ablation has been shown to reduce the risk of ventricular tachycardia (VT) recurrence and ICD therapy, including shocks, without affecting mortality in patients with documented VT undergoing ICD implantation.(5,6) We recently reported that successful late potential (LP) abolition reduces th…”
BackgroundMethodCronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.03.014 · Cited by 139
Outcomes of Cardiac Perforation Complicating Catheter Ablation of Ventricular Arrhythmias
Tokuda, M., Kojodjojo, P., Epstein, L. M., Koplan, B. A., Michaud, G. F., Tedrow, U. B., Stevenson, W. G., & John, R. M. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.963413 · Cited by 126
Kim, Y., Chen, S., Ernst, S., Guzmán, C., Han, S., Kalarus, Z. F., Labadet, C., Lin, Y.-J., Lo, L., Nogami, A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12308 · Cited by 132
Diagnosis, management, and outcomes of patients with syncope and bundle branch block
Moya, A., Garcia-Civera, R., Croci, F., Menozzi, C., Brugada, J., Ammirati, F., Del Rosso, A., Bellver-Navarro, A., Garcia-Sacristan, J., Bortnik, M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr071 · Cited by 124
“In addition, the rate of appropriate discharges in patients who received an ICD due to VT inducibility at EPS was similar to the discharge rate described in different published series in patients with ICD.21,22 This similarity suggests that in our study, inducibility identified the patients who were at risk of develop…”
ResultCatheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia
Sapp, J. L., TANG, A. S. L., Parkash, R., Stevenson, W. G., Healey, J. S., Gula, L. J., Nair, G. M., Essebag, V., Rivard, L., Roux, J.-F., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2409501 · Cited by 124
Implantable Cardioverter-Defibrillator Shocks: Epidemiology, Outcomes, and Therapeutic Approaches
Borne, R. T., Varosy, P. D., & Masoudi, F. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.428 · Cited by 134
“The prophylactic use of catheter ablation on the rate of ICD therapy in secondary prevention patients was examined with 128 patients who were randomized to either catheter ablation using a substrate-based approach or no ablation.(60) In the ablation group, there was a 65% lower risk of receiving ICD therapy (ATP or sh…”
The evaluation and management of electrical storm.
Eifling, M., Razavi, M., & Massumi, A. (2011) · Europe PMC (PubMed Central) · Cited by 123
Braunschweig, F., Boriani, G., Bauer, A., Hatala, R., Herrmann‐Lingen, C., Kautzner, J., Pedersen, S. S., Pehrson, S. M., Ricci, R. P., & Schalij, M. J. (2010) · EP Europace · doi:10.1093/europace/euq316 · Cited by 124
“More recently, the concept of prophylactic catheter ablation of VT in post-myocardial infarction patients with a secondary ICD indication has been introduced.(13,14) However, the results of larger studies should be awaited before prophylactic ablation can be recommended.”
BackgroundInfarct-Related Ventricular Tachycardia
Anter, E., Kléber, A. G., Rottmann, M., Leshem‐Rubinow, E., Barkagan, M., Tschabrunn, C. M., Contreras‐Valdes, F. M., & Buxton, A. E. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.04.007 · Cited by 115
“However, the excellent results of subendocardial resection surgery have not been reproduced by catheter ablation (10,13,32).”
BackgroundGami, A. S., Noheria, A., Lachman, N., Edwards, W. D., Friedman, P. A., Talreja, D., Hammill, S. C., Munger, T. M., Packer, D. L., & Asirvatham, S. J. (2010) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-010-9523-3 · Cited by 113
“Further, PVCs originating from or near the great artery have recently been shown to be a treatable cause for cardiomyopathy [5, 21–24].”
BackgroundMallidi, J. R., Nadkarni, G. N., Berger, R. D., Calkins, H. G., & Nazarian, S. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.12.015 · Cited by 115
Substrate mapping for unstable ventricular tachycardia
Santangeli, P., & Marchlinski, F. E. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.023 · Cited by 111
Ghanbari, H., Başer, K., Yokokawa, M., Stevenson, W. G., Bella, P. E. D., Vergara, P., Deneke, T., Kück, K., Kottkamp, H., Fei, S., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001404 · Cited by 110
“677 Several studies have demonstrated the efficacy of radiofrequency catheter ablation as adjunctive therapy in selected patients with recurrent, drug-resistant ventricular tachycardia (VT).(1,2) Despite major advances in the field, this therapy remains technically challenging and time-consuming.”
BackgroundTung, R. H., Mathuria, N. S., Michowitz, Y., Yu, R., Buch, E. F., Bradfield, J. S., Mandapati, R., Wiener, I., Boyle, N., & Shivkumar, K. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.967976 · Cited by 110
Piers, S. R. D., Leong, D. P., van Taxis, C. F. B. V. H., Tayyebi, M., Trines, S. A. I. P., Pijnappels, D. A., Delgado, V., Schalij, M. J., & Zeppenfeld, K. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000089 · Cited by 111
“Recent recommendations apply to all patients with structural heart disease, although evidence is limited and based on trials conducted in post-MI patients.(10,11) The risk–benefit ratio of VT ablation early in the therapeutic course may be different in patients with NICM, in whom VT ablation is reported to be less eff…”
Kalarus, Z. F., Svendsen, J. H., Capodanno, D., Dan, G., Maria, E. D., Görenek, B., Jędrzejczyk‐Patej, E., Mazurek, M., Podolecki, T., Sticherling, C., et al. (2019) · EP Europace · doi:10.1093/europace/euz163 · Cited by 117
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 108
Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease
Dukkipati, S. R., Koruth, J. S., Choudry, S., Miller, M. A., Whang, W., & Reddy, V. Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.030 · Cited by 109
“The SMASH-VT (Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia) study randomized patients with prior MI presenting with spontaneous VT/VF to ICD implantation alone or in combination with catheter ablation (63).”
MethodSelf-citationNatale, A., Raviele, A., Al‐Ahmad, A., Alfieri, O., Aliot, E., Almendral, J. M., Breithardt, G., Brugada, J., Calkins, H. G., Callans, D. J., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01686.x · Cited by 102
Self-citationAmiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia
Dorian (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6611 · Cited by 101
Yamashita, S., Cochet, H., Sacher, F., Mahida, S., Berte, B., Hooks, D. A., Sellal, J., Al-Jefairi, N., Frontera, A., Komatsu, Y., et al. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.003901 · Cited by 100
Vergara, P., Tzou, W. S., Tung, R. H., Brombin, C., Nonis, A., Vaseghi, M., Frankel, D. S., Biase, L. D., Tedrow, U. B., Mathuria, N. S., et al. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006730 · Cited by 106
Nielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00663-3 · Cited by 95
Wißner, E., Stevenson, W. G., & Kück, K. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs007 · Cited by 94
Al‐Khatib, S. M., Daubert, J. P., Anstrom, K. J., Daoud, E. G., Gonzalez, M. D., Saba, S., JACKSON, K. P., Reece, T. L., Gu, J., Pokorney, S. D., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12567 · Cited by 93
Catheter Ablation of Ventricular Arrhythmias
Shivkumar, K. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1615244 · Cited by 94
Acosta, J., Fernández‐Armenta, J., Penela, D., Andreu, D., Borràs, R., Vassanelli, F., Коршунов, В. В., Perea, R. J., de Caralt, T. M., Ortiz-Pérez, J. T., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.07.010 · Cited by 92
Multidisciplinary Critical Care Management of Electrical Storm
Jentzer, J. C., Noseworthy, P. A., Kashou, A. H., May, A. M., Chrispin, J., Kabra, R., Arps, K. E., Blumer, V. L., Tisdale, J. E., & Solomon, M. A. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.424 · Cited by 91
The diagnosis and management of ventricular arrhythmias
Roberts‐Thomson, K. C., Lau, D. H., & Sanders, P. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.15 · Cited by 94
“Secondary prevention Recurrence of VT is frequent, with approximately 50% of patients having subsequent episodes in the 2-year period following the initial event”
Lau, D. H., Clausen, C., Sosunov, E. A., Shlapakova, I. N., Anyukhovsky, E. P., Danilo, P., Rosen, T. S., Kelly, C. W., Duffy, H. S., Szabolcs, M. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.809301 · Cited by 88
Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
Lebedev, D. S., Mikhaylov, E. N., Neminuschiy, N. M., Golukhova, E. Z., Babokin, V. E., Bereznitskaya, V. V., Vasichkina, E. S., Garkina, S. V., Sp, G., Davtyan, K. V., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4600 · Cited by 95
Clinical Management and Prevention of Sudden Cardiac Death
Yousuf, O. K., Chrispin, J., Tomaselli, G. F., & Berger, R. D. (2015) · Circulation Research · doi:10.1161/circresaha.116.304555 · Cited by 92
“those with ICDs who presented with first appropriate shock for ventricular arrhythmia.(158) One hundred twenty-eight pa-”
BackgroundInfluentialThe role of catheter ablation in the management of ventricular tachycardia
Tanawuttiwat, T., Nazarian, S., & Calkins, H. G. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv421 · Cited by 83
“The rate of complications was 5% and no peri-procedural mortality was observed.(93,94) In contrast, when VT ablation is performed in patients with previous myocardial infarction selected after failure of prior anti-arrhythmic therapy, acute success is 49–89% and long-term recurrences occur in 34–57% of patients.”
BackgroundVentricular scars and ventricular tachycardia.
Stevenson, W. G. (2009) · PubMed Central · Cited by 80
Dinov, B., Arya, A., Bertagnolli, L., Schirripa, V., Schoene, K., Sommer, P., Bollmann, A., Rolf, S., & Hindricks, G. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001953 · Cited by 85
“ies suggesting benefits from earlier ablation in patients with coronary artery disease.(8,14) Because of its complexity,”
BackgroundMethodElectro-anatomic mapping systems in arrhythmias
Knackstedt, C., SCHAUERTE, P. N., & Kirchhof, P. F. (2008) · EP Europace · doi:10.1093/europace/eun225 · Cited by 90
Klein, T., Abdulghani, M., Smith, M. F., Huang, R., Asoğlu, R., Remo, B. F., Turgeman, A., Mesubi, O. O., Sidhu, S., Synowski, S. J., et al. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002105 · Cited by 78
“Current Approaches to VT Ablation Current VT ablation strategies primarily target the anatomic VT substrate, ie, surviving electrically conducting fibers within a myocardial scar.(17) As entrainment mapping is rarely possibly because of hemodynamic instability, anatomically based substrate-guided ablation procedures a…”
Carbucicchio, C., Andreini, D., Piperno, G., Catto, V., Conte, E., Cattani, F., Bonomi, A., Rondi, E., Piccolo, C., Vigorito, S., et al. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-01060-5 · Cited by 77
“Radiofrequency catheter ablation (RFCA) has evolved into a first-line modality of therapy for patients with scar-related ventricular arrhythmias (VAs) [1–3], being effective in the prevention of ventricular tachycardia (VT) recurrences and in the reduction of implantable cardioverter defibrillator (ICD) interventions…”
BackgroundAblation strategies for intramural ventricular arrhythmias
Neira, V., Santangeli, P., Futyma, P., Sapp, J. L., Valderrábano, M., Garcia, F. C., & Enriquez, A. A. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.02.010 · Cited by 75
Tung, R. H., Josephson, M. E., Reddy, V. Y., Reynolds, M. R., & on behalf of the SMASH‐VT Investigators (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01705.x · Cited by 73
Self-citation
Metadata
- Authors
- Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., Kralovec, S., Sediva, L., Ruskin, J. N., & Josephson, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-12-27
- Volume
- 357
- Issue
- 26
- Pages
- 2657-2665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2390777
- OpenAlex
- W2139803224
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 47 · 2023: 43 · 2022: 53 · 2021: 45 · 2020: 54 · 2019: 62 · 2018: 53 · 2017: 63 · 2016: 40 · 2015: 59 · 2014: 46 · 2013: 56 · 2012: 48
- FWCI
- 33.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23 HL 68064, K23HL077171, K23HL068064)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, ventricular tachyarrhythmia, myocardial infarction, sudden cardiac death, radiofrequency ablation, substrate-based ablation, myocardial scar, ICD shocks, secondary prevention
- MeSH terms
- Aged, Electric Countershock, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Ventricular Fibrillation, Multivariate Analysis, Death, Sudden, Cardiac, Catheter Ablation, Defibrillators, Implantable, Tachycardia, Ventricular, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.